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Introduction
The primary clinical objective after traumatic brain
injury (TBI) is to prevent secondary insults including
elevated ICP, a common sequel to the primary injury. The
concept is to prevent cerebral hypoxia by maintaining
sufficient oxygen delivery to the intracranial neural tissues.
This implies that cerebral blood flow (CBF), arterial
oxygen saturation and haemoglobin concentration in a
specific patient must be adequate. Intracranial pressure
(ICP) and cerebral perfusion pressure (CPP) monitoring is
recommended for severe TBI. There are several limitations
of ICP and CPP monitoring: the ICP devices are invasive,
distinct ICP and CPP target recommendations are uncertain
and not specific for the individual patient, CPP is not
equivalent to CBF and the relationship between CBF and
CPP depends on the status of CBF autoregulation.
Impairment of CBF autoregulation is a strong predictor of
TBI patients’ outcome [1-3]. In order to optimize the TBI
treatment decisions it is not enough to monitor ICP, ABP
and CPP. In this case it is necessary to know the status of
CBF autoregulation in real-time.
It is assumed that a negative correlation or the phase
shift close to 180° in the time courses of “slow B waves”
[4] (0.03 Hz to 0.008 Hz) of CBF and CPP reflects an
active change in cerebrovascular resistance and therefore
an intact CA system [2,3,5].
A positive correlation or the phase shift close to zero
of CBF and CPP shows a non-reacting cerebral vessels and
impaired CA system [2,3,5].
Control of CA in order to prevent secondary brain
insults and to guide ICP / CA targeted therapy requires
continuous uninterrupted and real-time CA monitoring.
Transcranial Doppler (TCD) technology together with non-
invasive ABP wave monitoring has been proposed for non-
invasive CA assessment [5]. A convenient way to assess
CA continuously under ICU conditions is to monitor the
moving Pearson’s correlation coefficient between
invasively measured ABP and ICP waves [2,6] at B wave
frequencies [4]. It is necessary to note that the moving
Pearson’s correlation coefficient in the case of CA
monitoring reflects the cosine of phase shift between the
waves under comparison (+1 is equivalent to 0 degrees
phase shift, and –1 is equivalent to 180 degrees phase
shift). The limitation of the slow B wave moving
correlation method is the intermittent nature of B waves.
The moving averaging of monitoring data to reduce the
uncertainty of CA estimation is the cause of 3 min to 10
min instrumental delay between actual CA changes and the
reflection of such changes in CA monitoring [2]. Such a
data delay time can be too big in the acute patients’
treatment. ABP and ICP respiratory waves are permanent
and up to 10 times more frequent compared with slow B
waves. The main advantage of natural or ventilator
supported respiratory wave application for CA assessment
is the possibility of continuous uninterrupted CA
monitoring with up to 10 times shorter monitoring data
delay time comparing with B wave method.
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Slow, respiratory and pulse ICP waves are the
consequences of the variations of intracranial blood
volume (IBV). All IBV waves can be monitored
continuously, non-invasively and in real-time by applying
ultrasonic “time-of-flight” Vittamed technique
[1,3,4,12,13].
Vittamed 505 CA monitor provides information about
the blood volume dynamics in the smallest vessels
responsible for cerebral blood flow autoregulation – small
arterial vessels and arterioles. It is impossible to obtain
such information using other known invasive or non-
invasive technologies.
The Vittamed 505 CA monitor (Fig. 1) was tested in
several intensive care units (ICU).
Fig. 1. Non-invasive cerebrovascular autoregulation monitor
Vittamed 505
Main technical parameters of Vittamed 505 CA
monitor
The main technical parameters of Vittamed 505 CA
monitor are as follows:
– Central frequency of transmitted ultrasonic pulse
spectrum is 1.05 MHz.
– Duration of transmitted ultrasonic pulses is 2.86 s
at a level of 0.5 of envelope amplitude, and its repetition
frequency is 1.0 kHz.
– Acoustic output parameters are derated spatial peak,
temporal-average intensity ISPTA.3 =0.86+/-0.02 mW/cm2;
derated spatial-peak, pulse average intensity ISPPA.3 =
1.18+/-0.03 W/cm2.
– Uncertainty of the time-of-flight measurements is
U=+/-SD=0.07 ns, and the bandwidth of non-invasive
intracranial pressure / volume pulse waves measuring
channel is from 0.6 Hz to 5.0 Hz, sampling frequency is 50
Hz.
– Power supply is AC 100 V – 240 V, 1.5A, 47Hz –
63Hz.
– The device meets requirements of EN 60601-1, EN
60601-2-37 and EN 60601-1-2 standards.
Belt type respiratory effort transducer is used in order
to generate the reference signal for Vittamed 505 monitor.
This respiratory effort reference signal replaces ABP
respiratory wave signal which is used in known invasive
slow intermittent wave CA monitoring technology.
Therefore, replacement it is not necessary to use invasive
or non-invasive ABP monitoring channel together with
Vittamed volumetric respiratory wave channel in Vittamed
505 CA monitor.
The typical clinical results of simultaneous invasive
and non-invasive monitoring of CA are illustrated in Fig. 2
a) and Fig. 2 b). It shows good agreement between
invasive R(ABP, ICP) and non-invasive R(ABP, IBV)
moving correlation coefficients. The individual variability
between these coefficients during one hour invasive and
non-invasive CA monitoring sessions was clinically
insignificant.
a)
b)
Fig. 2. Typical simultaneous invasive and non-invasive CA
monitoring data (one hour monitoring sessions): a) variability of
intact CA, b) variability of impaired CA
It was determined that the correlation coefficient
R(ICP; IBV) exceeded 0.9 when the amplitude of ICP B
waves was above 3 mmHg. Correlation coefficient
between invasive and non-invasive CA monitoring data
also exceeded 0.9 when the amplitudes of ICP B wave was
above 3 mmHg and the amplitude of ABP slow wave was
above 5 mmHg. To assess the similarity between the data
of invasive ICP slow waves and non-invasive IBV slow
waves, two types of data sets were evaluated for each
monitoring session. The data sets of the first type that
contain all measurement points were checked by
calculating the standard deviation and mean of differences
between the normalized invasive and non-invasive data
and by applying the correlation analysis. The data sets of
the second type that contain randomly selected data points
were evaluated by performing t – test of the paired data.
The values of t - criterion corresponding to each data set
were calculated using normalized data. Normalization was
performed dividing the original measurement data by
standard deviation. The calculated values of t-criterion
were checked in terms of inequality |t | < Tcrit (α = 0.05, n
= 50 ... 70), where, t is the calculated value of t – criterion
of paired samples, Tcrit is a critical value of t – statistics, α
is a significance level of the test, n is a number of
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randomly selected points. N = 83 samples of paired data
were found which satisfied the condition of the accepted
hypothesis on the equality of the mean values of
measurements under comparison. The investigated number
of samples was N = 87. The obtained proportion of
samples with positive decision was higher than the
proportion of interest (π = 0.95) and that confirms the
hypothesis on the coincidence of invasively and non-
invasively measured slow waves π = N+/N = 0.954 > 0.95.
The Bland Altman evaluation of invasively and non-
invasively measured slow B waves and the distribution of
the differences between these waves show the good
agreement between invasive and non-invasive data (SD =
0.089, p < 0.0001). The Bland Altman evaluation of
invasive and non-invasive CA monitoring data also shows
good agreement (SD = 0.05, p < 0.0001). Both invasive
and non-invasive methods of CA monitoring seem to give
the same diagnostic information about CA with the
uncertainty of experimental data, which is not important
for clinical practice.
b)
Fig. 3. Cerebrovascular autoregulation study:
a) one hour simultaneous invasive and non-invasive monitoring
of CA on TBI patient: iPRx is invasively measured correlation
factor between slow intermittent ICP and ABP waves, nPRx is
non-invasively measured correlation factor between slow
intermittent intracranial volumetric waves (Vittamed 505
monitor) and ABP waves, R is correlation between invasively and
non-invasively measured CA indexes iPRx(t) and nPRx(t);
b) Bland Altman plot of invasive and non-invasive CA
indexes, obtained from Fig. 3 a)
Relationship between ABP / IBV respiratory wave
phase shift and CA
Our data suggest that the phase shift not only between
slow intermittent B waves of ABP and IBV, but also the
phase shift between permanent respiratory waves is able to
differentiate between intact and impaired CA (Fig. 4). In
order to support the clinical results, the phase shift between
ABP and ICP waves was simulated on a computer using
the mathematical model described in [15,16], with
different values of autoregulation gains and time constants.
The simulations were performed at the frequencies 0.01
Hz, 0.1 Hz and 1.0 Hz (Fig. 4). The different time
constants of pial artery reactivity (Tpa) and reactivity of
arterioles (Tar) has been used in the case of intact CA. The
impairment of CA was simulated by reducing all gains in
CA model up to zero. Mathematical simulation shows that
the phase shift between ABP and ICP or IBV respiratory
waves under intact CA is higher than in the case of
impaired CA in the wide range of Tpa = [1.5 s; 10 s] and
Tar = [15 s; (Fig. 4). It is evident (Fig. 4) that the phase
shift between ABP and IBV can be used as an estimator of
CA impairment under ICU conditions when the
frequencies of natural or ventilator supported patient
respiration can change in the wide frequency band from
0.1 Hz to 0.45 Hz. This is an attractive alternative to slow
B wave application for CA monitoring because natural or
ventilator supported respiration is a permanent
physiological process which can be monitored
continuously, uninterruptedly and with the instrumental
delay time of monitoring data up to 10 times less
comparing with B wave method [4, 16].
ABP and IBV pulse wave phase shift clinical data shows
no difference in the cases of intact and impaired CA (Fig.
4). That is in agreement with simulation data. Phase shift
changes of permanent respiratory ABP waves and IBV
waves also permit continuous non-invasive CA monitoring
under ICU conditions without physical or pharmacological
stimulations of CA system. Vittamed non-invasive monitor
of CA (Fig. 1) in the case of respiratory wave application
does not need invasive or non-invasive ABP respiratory
wave monitoring.
Fig. 4. Phase shift between ABP and IBV waves in the cases of
intact and impaired CA comparing with intact CA / impaired CA
phase shift data of mathematical simulation:
Tpa – time constant of pial arteries,
Tar – time constant of arterioles;
Slow B wave data are presented in the frequency band 0.01 Hz ...
0.04 Hz, respiratory wave data in the frequency band 0.1 Hz ...
0.45 Hz and pulse wave data in the frequency band 0.65 Hz ... 3.0
Hz.
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In order to get information about ABP respiratory
wave it is possible to use the information about the cause
of mechanical respiration process – mechanical movement
of the human breast. This mechanical movement is
monitored applying non-invasive belt type respiratory
effort transducer. In this case Vittamed monitor is only real
– time CBF autoregulation monitor which is cost effective
and absolutely non-invasive.
Conclusions
1. The clinical study shows that the non-invasive
technology could be applied for continuous monitoring of
cerebrovascular autoregulation by using permanent
intracranial wave methodology.
2. Coincidence of invasively and non-invasively
measured ICP and IBV slow wave data has been
statistically significantly proved (>0.95, 87 monitoring
hours, 13 patients).
3. Phase shift changes of permanent respiratory ABP
waves and IBV waves permit continuous non-invasive CA
monitoring under ICU conditions without physical or
pharmacological stimulations of CA system.
4. The new monitor Vittamed 505 has been created
which uses both slow wave and respiratory wave
methodology.
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New non-invasive ultrasonic technology for CA monitoring has been created which uses both intracranial slow wave and respiratory
wave methodologies. The technology provides information about the intracranial blood volume dynamics in the smallest vessels
responsible for cerebral blood flow autoregulation – small arterial vessels and arterioles. The clinical study shows that the non-invasive
technology could be applied for continuous monitoring of CA by using slow intracranial wave or intracranial respiratory wave
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Создана новая ультразвуковая технология для мониторинга цереброваскулярной авторегуляции. Она основана на 
методологиях медленных интракраниальных волн и волн дыхания. Эта технология представляет информацию о динамике 
кровянного объёма в мелких кровяносных сосудах, ответственных за авторегуляцию мозгового  кровоснабжения. Клиническая 
студия новой неинвазионной технологии показала, что она может быть исползована для мониторинга цереброваскулярной 
авторегуляции при использовании методологий как медленных интракраниальных волн, так и интракраниальных объёмных 
волн дыхания. Ил. 4, библ. 12 (на английском языке; рефераты на английском, русском и литовском яз.).
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Technologija, 2008. – Nr. 5(85). – P. 93– 96.
Sukurta nauja ultragarsinė technologija cerebrovaskuliarinės autoreguliacijos monitoringui atlikti. Ji remiasi intrakranijinių lėtųjų
bangų ir kvėpavimo bangų metodologijomis. Ši technologija teikia informaciją apie intrakranijinės terpės kraujo tūrio dinamiką
smulkiausiuose kraujo induose, atsakinguose už cerebrovaskuliarinę autoreguliaciją – mažose arterinėse kraujagyslėse ir arteriolėse.
Naujos neinvazinės technologijos klinikinė studija parodė, kad ši technologija tinka cerebrovaskuliarinės autoreguliacijos monitoringui
atlikti taikant tiek intrakranijinių lėtųjų bangų, tiek intrakranijinių tūrinių kvėpavimo bangų metodologijas. Il. 4, bibl. 12 (anglų kalba;
santraukos anglų, rusų ir lietuvių k.).
